Table 1 Subject demographics and clinical characteristics.

From: Oral dextrose reduced procedural pain without altering cellular ATP metabolism in preterm neonates: a prospective randomized trial

Subject characteristics

30% dextrose

n = 47

Facilitated tucking

n = 53

30% dextrose and facilitated tucking

n = 52

P value

EGA at birth (weeks)

284/7 ± 32/7

291/7 ± 26/7

292/7 ± 24/7

0.535

EGA at time of study procedure (weeks)

312/7 ± 23/7

310/7 ± 43/7

313/7 ± 21/7

0.746

Gender

Male: 30 (64%)

Female: 17 (36%)

Male: 35 (66%)

Female: 18 (34%)

Male: 28 (54%)

Female: 24 (46%)

0.404

Apgar score, 0 min median (min, max)

5 (1, 9)

4 (0, 9)

5 (1, 9)

0.347

Apgar score, 5 min median (min, max)

8 (1, 9)

8 (1, 9)

8 (2, 10)

0.613

SNAPPE-II at time of study procedure

20.9 ± 16.2

21.2 ± 16.0

16.3 ± 14.0

0.256

Mode of oxygen delivery at time of study procedure

Spontaneous RA: 10

HFNC: 5

NCPAP: 23

NIPPV: 3

SIMV: 5

HFV: 1

Spontaneous RA: 9

HFNC: 12

NCPAP: 27

NIPPV: 3

SIMV: 0

HFV: 2

Spontaneous RA: 6

HFNC: 12

NCPAP: 25

NIPPV: 6

SIMV: 3

HFV: 0

0.204